Fibrinolytic agent

This page covers all Fibrinolytic agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Plasminogen / Fibrin, Plasminogen.

Targets

Plasminogen / Fibrin · Plasminogen

Marketed (1)

• Fibrinolytic twice daily · University of North Carolina, Chapel Hill · Cardiovascular
  Fibrinolytic agents dissolve blood clots by activating plasminogen to plasmin, which breaks down fibrin in thrombi.

Phase 3 pipeline (2)

• Urokinase thrombolysis · Capital Medical University · Cardiovascular
  Urokinase thrombolysis works by activating plasminogen to plasmin, which breaks down blood clots.
• non-immunogenic staphylokinase · Supergene, LLC · Cardiovascular
  Non-immunogenic staphylokinase is a genetically engineered enzyme that catalyzes the conversion of plasminogen to plasmin, thereby dissolving blood clots.

Phase 2 pipeline (1)

• Human Plasminogen · Kedrion S.p.A. · Cardiovascular
  Activates plasminogen to break down blood clots